A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
F Priddy, S Chalkias, B Essink, J Whatley… - Expert Review of …, 2024 - Taylor & Francis
ABSTRACT Introduction Vaccination against SARS-CoV-2 is an integral pillar of the public
health approach to COVID-19. With the emergence of variants of concern that increase …
health approach to COVID-19. With the emergence of variants of concern that increase …
Design and analysis heterogeneity in observational studies of COVID-19 booster effectiveness: A review and case study
We investigated the design and analysis of observational booster vaccine effectiveness (VE)
studies by performing a sco** review of booster VE literature with a focus on study design …
studies by performing a sco** review of booster VE literature with a focus on study design …
Real-world effectiveness of a third dose of mRNA-1273 versus BNT162b2 on inpatient and medically attended COVID-19 among immunocompromised US adults
Introduction Recent data have shown elevated infection rates in several subpopulations at
risk of SARS-CoV-2 infection and COVID-19, including immunocompromised (IC) …
risk of SARS-CoV-2 infection and COVID-19, including immunocompromised (IC) …
Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions
A Kawai, T Shimizu, H Tanaka, S Shichinohe… - Molecular Therapy, 2024 - cell.com
Messenger RNA vaccines based on lipid nanoparticles (mRNA-LNPs) are promising
vaccine modalities. However, mRNA-LNP vaccines frequently cause adverse reactions such …
vaccine modalities. However, mRNA-LNP vaccines frequently cause adverse reactions such …
Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021 …
JG Petrie, JP King, DL McClure… - Influenza and Other …, 2023 - Wiley Online Library
Background US recommendations for COVID‐19 vaccine boosters have expanded in terms
of age groups covered and numbers of doses recommended, whereas evolution of Omicron …
of age groups covered and numbers of doses recommended, whereas evolution of Omicron …
[HTML][HTML] Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study
JH Ku, LS Sy, L Qian, BK Ackerson, Y Luo, JE Tubert… - Vaccine, 2023 - Elsevier
We evaluated relative vaccine effectiveness (rVE) of 4-vs. 3-dose mRNA-1273 against
SARS-CoV-2 infection, and COVID-19 hospitalization and death in immunocompetent adults …
SARS-CoV-2 infection, and COVID-19 hospitalization and death in immunocompetent adults …
Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant
G Laghlali, MJ Wiest, D Karadag, P Warang… - Molecular Therapy, 2024 - cell.com
Current COVID-19 mRNA vaccines delivered intramuscularly (IM) induce effective systemic
immunity, but with suboptimal immunity at mucosal sites, limiting their ability to impart …
immunity, but with suboptimal immunity at mucosal sites, limiting their ability to impart …
Enhanced mucosal B-and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a …
G Laghlali, MJ Wiest, D Karadag, P Warang… - bioRxiv, 2024 - biorxiv.org
Current COVID-19 mRNA vaccines delivered intramuscularly (IM) induce effective systemic
immunity, but with suboptimal immunity at mucosal sites, limiting their ability to impart …
immunity, but with suboptimal immunity at mucosal sites, limiting their ability to impart …
[HTML][HTML] Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from …
N Nuraini, FN Soekotjo, A Alifia, KK Sukandar… - Heliyon, 2023 - Elsevier
Objectives Primary and booster vaccinations are crucial in COVID-19 control. This study
aimed to assess the minimum booster coverage to hamper potential surge of COVID-19 …
aimed to assess the minimum booster coverage to hamper potential surge of COVID-19 …
Relative Effectiveness and Waning of a Third Dose of mRNA COVID-19 Vaccine in Medicare Beneficiaries Aged 65 Years and Older during the BA. 1/BA. 2 Omicron …
Y Lu, K Matuska, R McEvoy, HS Izurieta… - The Journal of …, 2024 - academic.oup.com
Background We assessed the added benefit and waning effectiveness of a third COVID-19
vaccine dose (original formula) for preventing COVID-19-related outcomes. Methods We …
vaccine dose (original formula) for preventing COVID-19-related outcomes. Methods We …